mani
ageassoci
chang
respiratori
pulmonari
immun
system
chang
includ
decreas
volum
thorac
caviti
reduc
lung
volum
alter
muscl
aid
respir
muscl
function
cellular
level
age
popul
less
effici
elderli
popul
less
pulmonari
reserv
cough
strength
decreas
elderli
popul
due
anatom
chang
muscl
atrophi
clearanc
particl
lung
mucociliari
elev
decreas
associ
ciliari
dysfunct
mani
complex
chang
immun
age
contribut
increas
suscept
infect
includ
less
robust
immun
respons
innat
adapt
immun
system
consid
agerel
chang
lung
pulmonari
diseas
signific
consequ
age
popul
chronic
lower
respiratori
tract
diseas
third
lead
caus
death
peopl
age
year
older
larg
grow
age
popul
critic
understand
bodi
chang
age
impact
entir
respiratori
system
understand
age
process
lung
necessari
order
provid
optim
care
age
popul
review
focus
nonpatholog
age
process
lung
includ
structur
chang
chang
muscl
function
pulmonari
immunolog
function
special
consider
obstruct
lung
diseas
elderli
pulmonari
diseas
signific
consequ
age
popul
chronic
lower
respiratori
tract
diseas
defin
asthma
emphysema
chronic
bronchiti
bronchiectasi
chronic
obstruct
pulmonari
diseas
copd
third
lead
caus
death
peopl
age
year
older
accord
censu
data
us
popul
million
peopl
older
age
higher
previou
censu
addit
popul
age
increasingli
faster
rate
year
popul
age
year
increas
compar
total
us
popul
increas
larg
rapidli
grow
age
popul
critic
understand
bodi
chang
age
impact
entir
respiratori
system
understand
age
process
lung
necessari
order
provid
optim
care
age
popul
structur
thorac
caviti
hous
protect
lung
vital
optim
lung
function
chang
spine
muscl
rib
time
age
impact
normal
lung
function
peopl
normal
age
narrow
intervertebr
disk
space
caus
kyphosi
curvatur
spine
curvatur
decreas
space
rib
creat
smaller
chest
caviti
small
amount
anterior
curvatur
kyphosi
thorac
spine
normal
angl
greater
percentil
normal
defin
hyperkyphosi
age
kyphosi
angl
begin
increas
rapidli
women
men
mean
women
age
year
mean
women
year
age
preval
incid
hyperkyphosi
report
older
adult
vari
approxim
among
men
women
studi
nonsmok
women
variabl
degre
thorac
kyphosi
lombardi
et
al
found
increas
vertebr
angl
signific
declin
fraction
exhal
volum
second
fev
vital
capac
vc
spirometri
test
effect
signific
kyphot
angl
culham
et
al
hypothes
effect
decreas
thorac
caviti
size
alon
due
rib
space
narrow
decreas
length
intercost
muscl
angl
muscl
fiber
relat
rib
may
also
affect
effici
decreas
movement
lower
rib
inspir
chang
structur
base
origin
insert
muscl
addit
structur
chang
chang
intrins
function
muscl
age
overal
muscl
function
bodi
decreas
annual
age
age
associ
reduc
inspiratori
expiratori
respiratori
muscl
strength
respiratori
muscl
declin
lead
inabl
ventil
face
increas
demand
seen
respiratori
diseas
also
evid
cellular
level
muscl
elderli
individu
less
mitochondri
adenosin
triphosph
reserv
sustain
sudden
increas
metabol
demand
elderli
person
becom
ill
pneumonia
therefor
increas
metabol
demand
oxygen
set
decreas
respiratori
muscl
strength
decreas
cellular
energi
reserv
decreas
overal
muscl
function
may
abl
meet
demand
lead
increas
risk
respiratori
failur
older
individu
age
decreas
abil
clear
mucu
lung
two
mechan
primarili
contribut
declin
reduc
cough
strength
alter
bodi
abil
clear
particl
airway
first
cough
play
vital
role
clear
mucu
airway
cough
maneuv
requir
gener
high
forc
expiratori
flow
cough
maneuv
inspiratori
muscl
contract
allow
lung
take
larg
tidal
volum
necessari
augment
sustain
high
expiratori
flow
next
expiratori
muscl
contract
build
high
posit
intrapleur
intraairway
pressur
develop
peak
expiratori
flow
rate
final
glotti
open
cough
occur
mucu
expel
airway
mouth
decreas
strength
respiratori
muscl
greatli
impact
individu
abil
gener
forc
requir
effect
cough
age
associ
inspiratori
expiratori
respiratori
muscl
strength
reduct
polkey
et
al
show
decreas
transdiaphragmat
pressur
gradient
surrog
diaphragm
strength
older
subject
age
compar
younger
subject
age
tolep
et
al
compar
maximum
transdiaphragmat
pressur
pdimax
obtain
voluntari
maxim
inspiratori
effort
nine
young
year
ten
elderli
year
subject
found
averag
pdimax
elderli
subject
cm
h
significantli
lower
averag
pdimax
younger
subject
cm
h
specif
agerel
atrophi
muscl
fiber
term
sarcopenia
may
also
explain
reduc
respiratori
strength
elderli
decreas
muscl
fiber
strength
high
age
complex
chang
involv
mitochondria
muscl
fiber
disorgan
agerel
muscl
fiber
transit
metabol
shift
age
muscl
also
explain
reduct
muscl
strength
mucociliari
elev
refer
action
ciliat
cell
along
upper
lower
airway
beat
synchroni
trap
clear
mucu
foreign
particl
lung
upper
airway
nasal
mucociliari
cell
work
remov
larg
particl
enter
smaller
airway
lower
airway
mucociliari
cell
remov
fine
particl
airway
longer
period
time
alter
clearanc
larg
small
particl
age
de
oliveiramaul
et
al
use
clearanc
saccharin
inhal
nare
healthi
subject
measur
larg
airway
nasal
mucociliari
function
demonstr
peopl
age
delay
nasal
mucociliari
clearanc
time
saccharin
compar
subject
year
age
use
radiolabel
particl
travel
past
upper
airway
enter
smaller
airway
healthi
nonsmok
subject
svartengren
age
lung
alon
neg
associ
airway
clearanc
radiolabel
particl
day
associ
age
decreas
clearanc
mucociliari
elev
may
due
beat
frequenc
cilia
studi
beat
frequenc
cilia
confound
presenc
cigarett
smoke
larg
impact
beat
frequenc
age
statist
signific
predictor
decreas
beat
frequenc
impact
structur
function
chang
creat
age
process
sum
figur
addit
agerel
structur
chang
lung
advanc
age
contribut
system
immun
dysfunct
particular
interest
basal
activ
innat
immun
system
age
individu
absenc
immunolog
threat
phenomenon
refer
inflammag
mark
elev
level
tissu
circul
proinflammatori
cytokin
age
subject
specif
increas
level
interleukin
il
tumor
necrosi
observ
age
rodent
human
studi
theoret
heighten
level
cytokin
absenc
immunolog
threat
infecti
target
may
contributori
factor
reduc
elast
destruct
delic
lung
parenchyma
advanc
age
relat
inflammag
blunt
immun
respons
known
immunosenesc
follow
pathogen
threat
tissu
injuri
multipl
studi
establish
reduc
level
mediat
nitric
oxid
monocyt
chemoattract
macrophag
inflammatori
differ
type
antigen
stimul
age
anim
basal
level
inflamm
exampl
elev
level
suggest
contribut
subsequ
immunosenesc
follow
immun
challeng
use
model
knockout
mice
gomez
et
al
demonstr
restor
cytokin
product
follow
lipopolysaccharid
lp
challeng
age
knockout
anim
level
compar
young
wildtyp
data
suggest
basal
elev
circul
observ
age
wildtyp
anim
prior
stimul
may
contribut
inabl
upregul
cytokin
product
presenc
infecti
threat
repres
lp
addit
cytokin
alter
age
recent
data
demonstr
role
microrna
inflammag
cellular
senesc
specif
microrna
associ
senesc
associ
proinflammatori
statu
set
vascular
remodel
togeth
data
support
relationship
inflammag
immunosenesc
suggest
disrupt
balanc
proand
antiinflammatori
mediat
result
baselin
proinflammatori
environ
advanc
age
subsequ
dampen
appropri
innat
adapt
immun
respons
figur
addit
reduc
activ
data
support
shift
tempor
respons
injuri
age
initi
immunosenesc
time
result
protract
immun
respons
chronic
inflamm
studi
discuss
depth
later
context
pulmonari
inflamm
age
howev
import
consid
imbal
immun
mediat
delay
immun
activ
protract
cours
inflamm
may
result
increas
morbid
mortal
age
individu
follow
infect
environment
exposur
system
injuri
lung
immunolog
defens
complex
resourc
util
innat
adapt
immun
respons
inhal
antigen
innat
immun
critic
first
line
defens
lung
adapt
immun
acquir
immun
antigenspecif
requir
ward
encapsul
bacteria
virus
intracellular
pathogen
form
immun
reli
immunolog
memori
lymphocyt
product
antibodi
nonself
threat
import
chang
innat
immunolog
respons
occur
age
toll
like
receptor
tlr
key
context
age
conflict
data
regard
impact
age
murin
human
express
tlr
downstream
signal
mediat
murin
studi
monocyt
macrophag
report
reduc
express
one
sever
tlr
anoth
report
demonstr
alter
downstream
tlr
signal
involv
reduct
signal
support
studi
human
monocyt
age
subject
dampen
signal
associ
diminish
phosphoryl
addit
author
observ
reduct
chang
express
data
diverg
age
impact
tlr
express
data
suggest
alter
tlr
pathway
play
role
agerel
aberr
initi
innat
immun
respons
may
contribut
inabl
rapidli
recogn
erad
pathogen
studi
cigarett
smoke
exposur
elev
express
nuclear
transloc
nuclear
murin
neutrophil
chemokin
observ
age
mice
accompani
protract
neutrophilia
lung
parenchyma
moreov
follow
exposur
environment
toxin
diesel
exhaust
increas
pulmonari
neutrophilia
lung
parenchyma
led
congest
delay
clearanc
age
anim
compar
young
mice
data
suggest
inhal
pollut
caus
prolong
aberr
pulmonari
immun
respons
may
translat
increas
tissu
damag
play
part
environment
agerel
patholog
like
copd
pulmonari
infect
francisella
tularensi
age
rodent
demonstr
delay
product
neutrophil
chemokin
conjunct
attenu
neutrophil
recruit
earli
time
point
support
concept
aberr
initi
immun
respons
age
later
time
point
inocul
lp
respiratori
tract
age
mice
associ
subsequ
heighten
level
chemokin
linger
pulmonari
neutrophilia
hour
age
anim
compar
young
consid
delic
lung
alveolar
architectur
highli
hydrolyt
enzymat
degranul
product
activ
neutrophil
may
contribut
excess
tissu
damag
reduc
lung
function
time
cell
number
cytotox
antibodi
qualiti
quantiti
morbid
mortal
age
lung
addit
agerel
perturb
recruit
follow
inhal
injuri
infecti
insult
mclachlan
et
al
examin
cytotox
activ
monocyt
older
patient
compar
younger
patient
respons
lp
exposur
found
older
patient
display
less
reactiv
oxygen
speci
ro
cytotox
gener
product
ro
reactiv
nitrogen
intermedi
rni
key
function
proinflammatori
macrophag
respons
activ
type
helper
cell
pathway
alter
macrophag
polar
mark
reduc
ro
rni
report
advanc
age
support
studi
mclachlan
et
al
alveolar
macrophag
age
rat
reduc
basal
lpsactiv
level
ro
rni
lab
other
also
demonstr
age
associ
lower
level
induc
nitric
oxid
synthas
ino
enzym
regul
product
ro
rni
control
receptor
conjunct
chang
macrophag
phenotyp
cytotox
other
found
neutrophil
older
individu
year
produc
less
superoxid
chang
reactiv
implic
compromis
host
defens
age
addit
chang
innat
system
function
age
chang
seen
adapt
immun
age
order
activ
band
cell
dendrit
cell
dc
must
migrat
site
tissu
injuri
infect
local
lymph
node
sever
studi
demonstr
dc
age
mice
show
poor
migrat
home
dc
migrat
respons
chemokin
key
dc
chemokin
local
lymph
node
bind
chemokin
receptor
type
present
dc
cell
membran
reduc
age
mice
compar
young
interestingli
follow
respiratori
infect
lung
age
mice
either
mous
hepat
respiratori
syncyti
viru
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
elev
express
prostaglandin
correl
reduc
home
lung
dc
region
lymph
node
cell
activ
function
antagon
prostaglandin
result
upregul
chemokin
receptor
type
critic
receptor
dc
migrat
improv
dc
home
drain
lymph
node
subsequ
improv
cell
activ
surviv
viral
infect
mani
adapt
immun
function
ineffici
age
thymu
primarili
respons
produc
cell
replac
fatti
tissu
age
year
lead
increas
memori
cell
rel
cell
cell
reduc
age
anim
human
rel
memori
cell
counterpart
regard
cell
suggest
repeat
latent
cytomegaloviru
infect
may
result
expans
memori
cell
diminish
cell
pool
moreov
prolif
aptitud
cell
age
donor
appear
reduc
follow
cell
receptor
engag
highdos
antibodi
comparison
young
control
suggest
weaker
novel
pathogenspecif
immun
respons
meyer
et
al
look
ratio
cell
bronchoalveolar
lavag
fluid
young
versu
old
normal
volunt
found
increas
ratio
function
age
suggest
fewer
cell
avail
convert
memori
cell
face
novel
infect
recent
forkhead
box
transcript
factor
known
play
role
embryon
thymu
develop
shown
play
critic
role
prevent
thymic
involut
preserv
cell
subset
age
overexpress
forkhead
box
demonstr
increas
earli
thymic
progenitor
decreas
splenic
memori
cell
increas
splenic
cell
data
suggest
possibl
potenti
target
increas
number
cell
age
individu
increas
abil
elderli
respond
novel
antigen
antibodysecret
capac
b
cell
reduc
age
perhap
lead
less
robust
immunolog
respons
preval
copd
two
three
time
higher
peopl
age
project
copd
move
sixth
third
lead
caus
death
worldwid
rotterdam
studi
found
healthi
without
copd
one
six
women
one
four
men
develop
copd
later
life
risk
develop
copd
come
year
respect
cigarett
smoke
greatest
risk
factor
develop
copd
genet
suscept
individu
copd
character
airway
lung
inflamm
mucociliari
dysfunct
alveolar
destruct
airway
fibrosi
increas
burden
copd
seen
elderli
popul
may
due
ageassoci
chang
structur
function
lung
increas
pathogenet
suscept
copd
chang
describ
elderli
lifelong
nonsmok
character
airspac
dilat
result
loss
support
tissu
without
alveolar
wall
destruct
similar
chang
seen
copd
european
respiratori
societi
standard
diagnosi
classif
copd
assess
measur
ratio
fev
forc
vital
capac
fvc
fev
peak
age
year
begin
declin
age
annual
rate
declin
age
ml
per
year
declin
loss
ml
per
year
age
fvc
begin
declin
later
life
fev
slower
pace
unparallel
rate
declin
use
fev
fvc
ratio
alon
diagnos
copd
repres
copd
diagnosi
patholog
may
exist
complic
matter
ohar
et
al
found
copd
underdiagnos
unit
state
argu
due
underutil
spirometri
screen
test
copd
therefor
recommend
practition
combin
spirometri
symptom
typic
copd
util
diagnosi
copd
elderli
copd
often
associ
multipl
comorbid
effect
overal
sever
diseas
includ
osteoporosi
mental
ill
malnutrit
risk
cardiovascular
diseas
skelet
muscl
dysfunct
low
bodi
mass
index
commonli
seen
patient
copd
shown
invers
relat
mortal
copd
anxieti
depress
preval
comorbid
also
shown
relat
neg
outcom
copd
estim
individu
copd
depress
compar
preval
gener
popul
cognit
impair
common
associ
copd
elderli
estim
anywher
age
person
copd
concomit
dementia
neurocognit
impair
may
relat
hypoxemia
hypercapnia
associ
copd
may
also
due
common
occurr
cardiovascular
diseas
elderli
copd
condit
certainli
impact
abil
toler
compli
prescrib
copd
therapi
inhal
bronchodil
therapi
mainstay
treatment
manag
copd
treatment
option
vari
includ
meter
dose
inhal
dri
powder
inhal
nebul
formul
mani
factor
may
impact
effect
treatment
use
elderli
copd
popul
includ
arthriti
weak
poor
manual
dexter
cognit
impair
visual
limit
care
consider
regard
treatment
recommend
must
made
age
copd
popul
mani
ageassoci
chang
respiratori
pulmonari
system
size
thorac
caviti
decreas
limit
lung
volum
alter
muscl
aid
respir
muscl
function
cellular
level
less
effici
decreas
reserv
cough
strength
reduc
elderli
popul
due
anatom
chang
muscl
atrophi
clearanc
particl
lung
mucociliari
elev
neg
impact
associ
ciliari
dysfunct
mani
complex
chang
immun
age
increas
suscept
infect
includ
less
robust
immun
respons
innat
adapt
immun
system
final
copd
highest
preval
elderli
deserv
special
consider
regard
treatment
fragil
popul
addit
research
need
improv
understand
determin
lung
age
effect
lung
immun
author
report
conflict
interest
work
